Prevention and treatment of relapse after stem cell transplantation with immunotherapy
Standard
Prevention and treatment of relapse after stem cell transplantation with immunotherapy. / Gökbuget, Nicola; Canaani, Jonathan; Nagler, Arnon; Bishop, Michael; Kröger, Nicolaus; Avigan, David.
In: BONE MARROW TRANSPL, Vol. 53, No. 6, 06.2018, p. 664-672.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Prevention and treatment of relapse after stem cell transplantation with immunotherapy
AU - Gökbuget, Nicola
AU - Canaani, Jonathan
AU - Nagler, Arnon
AU - Bishop, Michael
AU - Kröger, Nicolaus
AU - Avigan, David
PY - 2018/6
Y1 - 2018/6
N2 - Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.
AB - Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.
KW - Journal Article
KW - Review
U2 - 10.1038/s41409-018-0232-3
DO - 10.1038/s41409-018-0232-3
M3 - SCORING: Review article
C2 - 29795427
VL - 53
SP - 664
EP - 672
JO - BONE MARROW TRANSPL
JF - BONE MARROW TRANSPL
SN - 0268-3369
IS - 6
ER -